Latest News

Image description

FDA approves Lupin generic

Tobramycin Inhalation Solution USP, 300 mg/5 ml, a generic version of Novartis Pharmaceuticals’ TOBI 300 mg/5 ml, is indicated for the management of cystic fibrosis patients with P. aeruginosa.